Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Open Orphan Plc (GB:HVO)
LSE:HVO
Holding GB:HVO?
Track your performance easily
HVO Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range16.76p - 32.00p
Previous Close27.3p
Volume760.38K
Average Volume (3M)2.96M
Market Cap
£186.08M
Enterprise Value163.20M
Total Cash (Recent Filing)£36.97M
Total Debt (Recent Filing)£14.09M
Price to Earnings (P/E)11.5
Beta0.80
Next Earnings
Jun 25, 2025EPS EstimateN/A
Last Dividend Ex-Date
Apr 18, 2024Dividend Yield0.73%
Share Statistics
EPS (TTM)0.02
Shares Outstanding680,371,877
10 Day Avg. Volume2,739,624
30 Day Avg. Volume2,959,394
Standard Deviation0.21
R-Squared0.03
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)455.00
Price to Sales (P/S)2.88
Price to Cash Flow (P/CF)35.50
P/FCF Ratio124.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
35.00pPrice Target Upside28.21% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Open Orphan Plc News
PremiumCompany Announcements
hVIVO Plc to Present at London Healthcare Conference
PremiumCompany Announcements
hVIVO Incentivizes Leadership with New LTIP
PremiumCompany Announcements
Open Orphan Plc Triumphs in RSV Antiviral Trial
PremiumCompany Announcements
Open Orphan Plc Unveils Expanded hLAB ServicesPremiumCompany Announcements
Open Orphan Reports Major Ownership Change
PremiumCompany Announcements
Open Orphan Plc Announces Major Stakeholder Increase
PremiumCompany Announcements
Octopus Investments Ups Stake in Open Orphan Plc
PremiumCompany Announcements
Open Orphan Plc Announces Record RevenuesOptions Prices
Currently, No data available
---
Ownership Overview
0.59% Insiders
0.01% Mutual Funds
― Other Institutional Investors
99.38% Public Companies and
Individual Investors
HVO FAQ
What was Open Orphan Plc’s price range in the past 12 months?
Open Orphan Plc lowest share price was 16.76p and its highest was 32.00p in the past 12 months.
What is Open Orphan Plc’s market cap?
Currently, no data Available
When is Open Orphan Plc’s upcoming earnings report date?
Open Orphan Plc’s upcoming earnings report date is Jun 25, 2025 which is in 227 days.
How were Open Orphan Plc’s earnings last quarter?
Open Orphan Plc released its earnings results on Sep 10, 2024. The company reported 0.008p earnings per share for the quarter, beating the consensus estimate of N/A by 0.008p.
Is Open Orphan Plc overvalued?
According to Wall Street analysts Open Orphan Plc’s price is currently Undervalued.
Does Open Orphan Plc pay dividends?
Open Orphan Plc pays a Notavailable dividend of 0.2p which represents an annual dividend yield of 0.73%. See more information on Open Orphan Plc dividends here
What is Open Orphan Plc’s EPS estimate?
Open Orphan Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Open Orphan Plc have?
Open Orphan Plc has 680,371,900 shares outstanding.
What happened to Open Orphan Plc’s price movement after its last earnings report?
Open Orphan Plc reported an EPS of 0.008p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.787%.
Which hedge fund is a major shareholder of Open Orphan Plc?
Currently, no hedge funds are holding shares in GB:HVO
---
Open Orphan Plc Stock Smart Score
Company Description
Open Orphan Plc
Open Orphan PLC is a European-focussed, rare and orphan drug consulting services platform. The company consists of four elements: a European clinical research organisation and consultancy; an orphan drug services business; a Virtual Rep and Data Access Platform consisting of physicians and key opinion leaders; and a Health Data Platform to partner with Patient Advocacy Groups. The company is targeting rapid growth in one of the fastest growing sectors in the global pharmaceutical industry targeting under-supplied treatment for life threatening or very serious diseases and rare disorders.
---
HVO Stock 12 Month Forecast
Average Price Target
35.00p
▲(28.21% Upside)
Technical Analysis
Best Analysts Covering HVO
1 Year
1 Year Success Rate
0/3 ratings generated profit
1 Year Average Return
-3.97%
reiterated a buy rating 2 months ago
Copying James Orsborne's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -3.97% per trade.
---